Introduction: Who Should Undergo Diagnostics and When

Epileptic encephalopathy typically appears very early in a child’s life, often during infancy or even in the newborn period. Parents and caregivers should seek diagnostic evaluation when they notice unusual movements or behaviors in their baby or young child that might signal seizures. These can include sudden stiffening of the body, repetitive jerking movements, clusters of brief spasms, or episodes where the child seems unresponsive or stares blankly for prolonged periods.^[1]

The timing of diagnosis matters greatly in epileptic encephalopathy. Because the abnormal electrical activity in the brain can contribute to developmental delays and loss of skills that were already learned, early recognition and prompt evaluation are crucial. If a baby experiences frequent seizures that are difficult to control with standard medications, or if developmental milestones begin to slow down or reverse after seizures start, these are important warning signs that warrant immediate medical attention.^[2]

Children who have already been diagnosed with seizures should undergo additional diagnostic testing if their condition changes. For example, if a child develops new types of seizures, experiences a noticeable decline in cognitive or behavioral function, or shows seizures that occur specifically during sleep, comprehensive diagnostic evaluation is necessary. Boys between ages 2 and 12 are particularly at risk for certain forms of epileptic encephalopathy that affect brain function during sleep, though these conditions can affect children of any gender.^[1]

Diagnostic Methods

Diagnosing epileptic encephalopathy requires a combination of different tests and examinations. The diagnosis cannot be made with a single test, as doctors need to understand both the seizure activity and how it affects brain development. The process involves careful observation of symptoms, specialized brain monitoring, imaging studies, and sometimes genetic or metabolic testing.^[3]

Clinical History and Physical Examination

The diagnostic journey begins with a detailed medical history and physical examination. Doctors will ask parents or caregivers to describe the episodes they’ve observed, including what the child was doing before the episode, exactly what happened during it, how long it lasted, and what the child was like afterward. Recording videos of these episodes on a phone can be extremely helpful for doctors to see what is happening. The physical examination looks for any neurological signs that might point to underlying brain problems or developmental delays.^[3]

Electroencephalography (EEG)

The electroencephalogram, or EEG, is the most important diagnostic tool for epileptic encephalopathy. This test records the brain’s electrical activity by placing small sensors called electrodes on the scalp. The sensors are attached with a paste or gel and connected to a machine that displays the brain’s electrical patterns on a screen or paper. The test is painless and safe—it only records signals, it doesn’t send any electricity into the brain.^[4]

In epileptic encephalopathy, the EEG typically shows very abnormal patterns. Different types of epileptic encephalopathy have characteristic EEG patterns that help doctors identify the specific syndrome. For example, early infantile epileptic encephalopathy shows a pattern called suppression burst, where bursts of high-voltage spikes alternate with periods when the brain’s electrical activity becomes very quiet or flat. This abnormal pattern appears during both waking and sleeping states, which is unusual and helps confirm the diagnosis.^[6]

For some forms of epileptic encephalopathy, especially those affecting older children, doctors need to record the EEG during sleep. Conditions like electrical status epilepticus during sleep (ESES) and continuous spike wave of sleep (CSWS) show their most dramatic abnormalities during non-REM sleep, when the EEG displays near-continuous spike waves. A regular daytime EEG might miss these patterns entirely, so overnight or extended EEG monitoring becomes necessary. An extended EEG that records brain activity for 24 hours or longer can capture both daytime and nighttime patterns and is most effective at detecting abnormalities.^[4]

The EEG serves multiple purposes beyond initial diagnosis. Doctors use it to monitor how well treatments are working over time. Since the goal of treatment is to reduce abnormal electrical activity in the brain, repeated EEG studies help determine whether medications or other therapies are having the desired effect. The degree to which EEG abnormalities improve often correlates with improvements in cognitive function, making it a valuable tool for guiding treatment decisions.^[9]

Brain Imaging Studies

Magnetic resonance imaging (MRI) scans provide detailed pictures of the brain’s structure and are essential in evaluating epileptic encephalopathy. An MRI uses powerful magnets and radio waves to create images—it does not use radiation like X-rays or CT scans do. The child lies still inside a large tube-shaped machine while the images are taken. Because young children often have difficulty staying still for the 30 to 60 minutes needed to complete the scan, sedation or anesthesia may be necessary.^[3]

MRI helps identify structural problems in the brain that might be causing or contributing to the epileptic encephalopathy. These can include brain malformations present from birth, such as areas where brain development went wrong (cortical malformations), or problems like hemimegalencephaly where one side of the brain is abnormally large. The MRI can also detect signs of previous injury to the brain or other abnormalities like porencephaly, where there are fluid-filled spaces in the brain tissue.^[6]

Computed tomography (CT) scans provide another way to look at brain structure. CT scans use X-rays to create cross-sectional images of the brain and are faster than MRI, which can be helpful in urgent situations. However, MRI provides more detailed images of the brain’s soft tissues and is generally preferred for diagnosing epileptic encephalopathy when time allows. Both imaging methods help doctors understand whether there is an identifiable brain abnormality that might be treatable with surgery.^[3]

Genetic and Metabolic Testing

Many cases of epileptic encephalopathy have genetic causes, meaning they result from changes or mistakes in specific genes. Genetic testing looks for these changes by analyzing DNA from a blood sample. Scientists have identified mutations in numerous genes that can cause epileptic encephalopathy, including ARX, CDKL5, SLC25A22, and STXBP1, among many others. Finding a specific genetic cause can help predict the course of the condition, guide treatment choices, and provide important information for families about recurrence risk in future pregnancies.^[6]

Some epileptic encephalopathies result from metabolic disorders—conditions where the body cannot properly process certain substances. These require specialized blood and urine tests to measure various chemicals and compounds. For example, doctors might test for conditions like cytochrome C oxidase deficiency or carnitine palmitoyl transferase II deficiency, which are metabolic problems that can cause epileptic encephalopathy. Identifying a metabolic cause is important because some of these conditions respond to specific dietary treatments or vitamin supplements.^[6]

Developmental and Neuropsychological Assessment

Because epileptic encephalopathy significantly affects development and cognitive function, comprehensive developmental assessments are an essential part of diagnosis. These evaluations test the child’s abilities in areas such as language, memory, attention, problem-solving, and motor skills. The assessments establish a baseline that shows which skills the child has and which are delayed or lost. This baseline becomes crucial for monitoring whether the child’s development improves, stays the same, or worsens over time with treatment.^[4]

For children with suspected Landau-Kleffner syndrome, specialized speech and language evaluations are particularly important. These children experience difficulty understanding and speaking words, and challenges recognizing voices and other sounds—a condition called verbal auditory agnosia. Sometimes these children are initially misdiagnosed with hearing loss, so hearing tests are also performed to rule out actual hearing problems. Behavioral assessments help identify conditions like attention deficit hyperactivity disorder (ADHD) that commonly occur alongside epileptic encephalopathy.^[4]

Diagnostics for Clinical Trial Qualification

When children with epileptic encephalopathy are considered for enrollment in clinical trials testing new treatments, they must undergo specific diagnostic tests that meet standardized criteria. Clinical trials require very precise documentation of the condition to ensure that all participants truly have the disorder being studied and that results can be accurately measured and compared.^[3]

The EEG remains the cornerstone diagnostic test for clinical trial qualification. Trials typically require documentation of the characteristic EEG pattern associated with the specific type of epileptic encephalopathy being studied. For trials of treatments for conditions with sleep-related electrical abnormalities, extended sleep EEG recordings are mandatory to document the percentage of sleep time affected by abnormal electrical activity. The trial protocols often specify exactly how long the EEG recording must be and what minimum level of abnormality must be present.^[3]

Seizure frequency and type must be carefully documented over a baseline period before a child can enter a clinical trial. Parents or caregivers typically keep detailed seizure diaries, recording every seizure—when it occurred, how long it lasted, and what it looked like. This baseline period, often lasting several weeks to months, establishes the child’s seizure pattern without the experimental treatment. Video recordings of seizures may also be required to confirm seizure types and ensure accurate classification.^[3]

Neuropsychological testing at specific intervals helps measure whether an experimental treatment affects cognitive function. Clinical trials evaluating treatments for epileptic encephalopathy particularly focus on whether interventions can prevent developmental decline or even improve cognitive abilities, not just reduce seizures. Standardized tests of memory, attention, language, and other cognitive domains are administered at the beginning of the trial and at scheduled follow-up points. These assessments must use validated tools that can detect even small changes in function.^[9]

Brain imaging, particularly MRI, is usually required for clinical trial enrollment to document any structural brain abnormalities and ensure that participants meet the study’s inclusion criteria. Some trials specifically enroll only children with or without certain types of brain malformations, making MRI documentation essential. The imaging also serves as a baseline to monitor for any unexpected changes during the trial.

Genetic testing results may be required for trials targeting specific genetic forms of epileptic encephalopathy. As researchers develop treatments tailored to particular genetic mutations, clinical trials increasingly focus on children with confirmed genetic diagnoses. Documentation of the specific genetic variant becomes a prerequisite for enrollment. Laboratory tests assessing liver and kidney function, blood counts, and other general health markers are standard requirements to ensure that participants are healthy enough to safely receive the experimental treatment.^[6]

The coordination of all these diagnostic tests for clinical trial qualification represents a significant undertaking for families and medical teams. However, participation in clinical trials offers access to potentially beneficial new treatments and contributes to advancing knowledge that may help future children with epileptic encephalopathy. The rigorous diagnostic standards ensure that trial results are reliable and that treatments proven effective in trials will work for similar patients in clinical practice.